請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71813
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 宋麗英(Li-Ying Sung) | |
dc.contributor.author | Yun-Hsin Wu | en |
dc.contributor.author | 吳昀昕 | zh_TW |
dc.date.accessioned | 2021-06-17T06:10:43Z | - |
dc.date.available | 2019-11-23 | |
dc.date.copyright | 2018-11-23 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-11-15 | |
dc.identifier.citation | Aguado, T., Gutierrez, F.J., Aix, E., Schneider, R.P., Giovinazzo, G., Blasco, M.A., Flores, I., 2017. Telomere Length Defines the Cardiomyocyte Differentiation Potency of Mouse Induced Pluripotent Stem Cells. Stem Cells 35, 362-373.
Armanios, M., Blackburn, E.H., 2012. The telomere syndromes. Nat. Rev. Genet. 13, 693-704. Arnold, S.J., Robertson, E.J., 2009. Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nat. Rev. Mol. Cell Biol. 10, 91-103. Badie, S., Escandell, J.M., Bouwman, P., Carlos, A.R., Thanasoula, M., Gallardo, M.M., Suram, A., Jaco, I., Benitez, J., Herbig, U., Blasco, M.A., Jonkers, J., Tarsounas, M., 2010. BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat. Struct. Mol. Biol. 17, 1461-1469. Bailey, S.M., Brenneman, M.A., Goodwin, E.H., 2004. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res. 32, 3743-3751. Batista, L.F., Pech, M.F., Zhong, F.L., Nguyen, H.N., Xie, K.T., Zaug, A.J., Crary, S.M., Choi, J., Sebastiano, V., Cherry, A., Giri, N., Wernig, M., Alter, B.P., Cech, T.R., Savage, S.A., Reijo Pera, R.A., Artandi, S.E., 2011. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402. Batra, H., Antony, V.B., 2015. Pleural mesothelial cells in pleural and lung diseases. Journal of thoracic disease 7, 964-980. Beumer, K.J., Trautman, J.K., Bozas, A., Liu, J.L., Rutter, J., Gall, J.G., Carroll, D., 2008. Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases. Proceedings of the National Academy of Sciences of the United States of America 105, 19821-19826. Blagoev, K.B., Goodwin, E.H., 2008. Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations. DNA Repair (Amst) 7, 199-204. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., Greider, C.W., 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34. Brambrink, T., Hochedlinger, K., Bell, G., Jaenisch, R., 2006. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proceedings of the National Academy of Sciences of the United States of America 103, 933-938. Cesare, A.J., Reddel, R.R., 2010. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet. 11, 319-330. Condic, M.L., 2014. Totipotency: what it is and what it is not. Stem cells and development 23, 796-812. Conti, L., Cattaneo, E., 2010. Neural stem cell systems: physiological players or in vitro entities? Nat. Rev. Neurosci. 11, 176-187. Deutsch, U., Dressler, G.R., Gruss, P., 1988. Pax 1, a member of a paired box homologous murine gene family, is expressed in segmented structures during development. Cell 53, 617-625. Dunham, M.A., Neumann, A.A., Fasching, C.L., Reddel, R.R., 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450. Ferron, S., Mira, H., Franco, S., Cano-Jaimez, M., Bellmunt, E., Ramirez, C., Farinas, I., Blasco, M.A., 2004. Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells. Development 131, 4059-4070. Fok, W.C., Niero, E.L.O., Dege, C., Brenner, K.A., Sturgeon, C.M., Batista, L.F.Z., 2017. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita. Stem cell reports 9, 409-418. Fox, I.J., Daley, G.Q., Goldman, S.A., Huard, J., Kamp, T.J., Trucco, M., 2014. Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (New York, N.Y.) 345, 1247391. Frenz, D.A., Liu, W., Williams, J.D., Hatcher, V., Galinovic-Schwartz, V., Flanders, K.C., Van de Water, T.R., 1994. Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120, 415-424. Ganan, Y., Macias, D., Duterque-Coquillaud, M., Ros, M.A., Hurle, J.M., 1996. Role of TGF beta s and BMPs as signals controlling the position of the digits and the areas of interdigital cell death in the developing chick limb autopod. Development 122, 2349-2357. Gasior, S.L., Olivares, H., Ear, U., Hari, D.M., Weichselbaum, R., Bishop, D.K., 2001. Assembly of RecA-like recombinases: distinct roles for mediator proteins in mitosis and meiosis. Proceedings of the National Academy of Sciences of the United States of America 98, 8411-8418. Gonzalo, S., Jaco, I., Fraga, M.F., Chen, T., Li, E., Esteller, M., Blasco, M.A., 2006. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416-424. Greider, C.W., Blackburn, E.H., 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413. Greider, C.W., Blackburn, E.H., 1987. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887-898. Guan, K., Rohwedel, J., Wobus, A.M., 1999. Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. Cytotechnology 30, 211-226. Gunes, C., Rudolph, K.L., 2013. The role of telomeres in stem cells and cancer. Cell 152, 390-393. Gurdon, J.B., 1962. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. Journal of embryology and experimental morphology 10, 622-640. Hall, B.K., Newman, S., 1991. Cartilage : molecular aspects. CRC Press, Boca Raton, Fla. Henson, J.D., Neumann, A.A., Yeager, T.R., Reddel, R.R., 2002. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610. Herrera, E., Samper, E., Blasco, M.A., 1999a. Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. EMBO J. 18, 1172-1181. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J.M., Lee, H.W., Blasco, M.A., 1999b. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., Yamanaka, S., 2009. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135. Hu, Z., Shi, Z., Guo, X., Jiang, B., Wang, G., Luo, D., Chen, Y., Zhu, Y.S., 2018. Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells. Cell & bioscience 8, 12. Huang, J., Wang, F., Okuka, M., Liu, N., Ji, G., Ye, X., Zuo, B., Li, M., Liang, P., Ge, W.W., Tsibris, J.C., Keefe, D.L., Liu, L., 2011. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res. 21, 779-792. Inoue, H., Nagata, N., Kurokawa, H., Yamanaka, S., 2014. iPS cells: a game changer for future medicine. EMBO J. 33, 409-417. Jayathilaka, K., Sheridan, S.D., Bold, T.D., Bochenska, K., Logan, H.L., Weichselbaum, R.R., Bishop, D.K., Connell, P.P., 2008. A chemical compound that stimulates the human homologous recombination protein RAD51. Proceedings of the National Academy of Sciences of the United States of America 105, 15848-15853. Kanai-Azuma, M., Kanai, Y., Gad, J.M., Tajima, Y., Taya, C., Kurohmaru, M., Sanai, Y., Yonekawa, H., Yazaki, K., Tam, P.P., Hayashi, Y., 2002. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129, 2367-2379. Kramer, J., Hegert, C., Guan, K., Wobus, A.M., Muller, P.K., Rohwedel, J., 2000. Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mechanisms of development 92, 193-205. Kulyk, W.M., Rodgers, B.J., Greer, K., Kosher, R.A., 1989. Promotion of embryonic chick limb cartilage differentiation by transforming growth factor-beta. Dev. Biol. 135, 424-430. Kuske, B., Savkovic, V., zur Nieden, N.I., 2011. Improved media compositions for the differentiation of embryonic stem cells into osteoblasts and chondrocytes. Methods in molecular biology (Clifton, N.J.) 690, 195-215. Le, R., Kou, Z., Jiang, Y., Li, M., Huang, B., Liu, W., Li, H., Kou, X., He, W., Rudolph, K.L., Ju, Z., Gao, S., 2014. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells. Cell stem cell 14, 27-39. Lee, H.W., Blasco, M.A., Gottlieb, G.J., Horner, J.W., 2nd, Greider, C.W., DePinho, R.A., 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574. Leonard, C.M., Fuld, H.M., Frenz, D.A., Downie, S.A., Massague, J., Newman, S.A., 1991. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev. Biol. 145, 99-109. Lewin, B., Krebs, J.E., Goldstein, E.S., Kilpatrick, S.T., 2014. Lewin's genes XI. Jones & Bartlett Learning, Burlington, MA. Lieber, M.R., 2010. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181-211. Liu, N., Schild, D., Thelen, M.P., Thompson, L.H., 2002. Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res. 30, 1009-1015. Ma, Y., Chen, W., Zhang, X., Yu, L., Dong, W., Pan, S., Gao, S., Huang, X., Zhang, L., 2016. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein. RNA biology 13, 605-612. Marion, R.M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M., Blasco, M.A., 2009. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell stem cell 4, 141-154. Mason, J.M., Logan, H.L., Budke, B., Wu, M., Pawlowski, M., Weichselbaum, R.R., Kozikowski, A.P., Bishop, D.K., Connell, P.P., 2014. The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res. 74, 3546-3555. Masson, J.Y., Tarsounas, M.C., Stasiak, A.Z., Stasiak, A., Shah, R., McIlwraith, M.J., Benson, F.E., West, S.C., 2001. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 15, 3296-3307. Muntoni, A., Reddel, R.R., 2005. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14 Spec No. 2, R191-196. Ochiai, H., Sakamoto, N., Fujita, K., Nishikawa, M., Suzuki, K., Matsuura, S., Miyamoto, T., Sakuma, T., Shibata, T., Yamamoto, T., 2012. Zinc-finger nuclease-mediated targeted insertion of reporter genes for quantitative imaging of gene expression in sea urchin embryos. Proceedings of the National Academy of Sciences of the United States of America 109, 10915-10920. Phornphutkul, C., Wu, K.Y., Gruppuso, P.A., 2006. The role of insulin in chondrogenesis. Mol. Cell. Endocrinol. 249, 107-115. Poh, Y.C., Chen, J., Hong, Y., Yi, H., Zhang, S., Chen, J., Wu, D.C., Wang, L., Jia, Q., Singh, R., Yao, W., Tan, Y., Tajik, A., Tanaka, T.S., Wang, N., 2014. Generation of organized germ layers from a single mouse embryonic stem cell. Nature communications 5, 4000. Roark, E.F., Greer, K., 1994. Transforming growth factor-beta and bone morphogenetic protein-2 act by distinct mechanisms to promote chick limb cartilage differentiation in vitro. Dev. Dyn. 200, 103-116. Rosen, D., Miller, S.C., DeLeon, E., Thompson, A.Y., Bentz, H., Mathews, M., Adams, S., 1994. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15, 355-359. Rudolph, K.L., Chang, S., Lee, H.W., Blasco, M., Gottlieb, G.J., Greider, C., DePinho, R.A., 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712. Sandell, L.J., Morris, N., Robbins, J.R., Goldring, M.B., 1991. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J. Cell Biol. 114, 1307-1319. Sandell, L.J., Nalin, A.M., Reife, R.A., 1994. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev. Dyn. 199, 129-140. Sarek, G., Marzec, P., Margalef, P., Boulton, S.J., 2015. Molecular basis of telomere dysfunction in human genetic diseases. Nat. Struct. Mol. Biol. 22, 867-874. Shamblott, M.J., Axelman, J., Wang, S., Bugg, E.M., Littlefield, J.W., Donovan, P.J., Blumenthal, P.D., Huggins, G.R., Gearhart, J.D., 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proceedings of the National Academy of Sciences of the United States of America 95, 13726-13731. Song, J., Yang, D., Xu, J., Zhu, T., Chen, Y.E., Zhang, J., 2016. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nature communications 7, 10548. Sperka, T., Song, Z., Morita, Y., Nalapareddy, K., Guachalla, L.M., Lechel, A., Begus-Nahrmann, Y., Burkhalter, M.D., Mach, M., Schlaudraff, F., Liss, B., Ju, Z., Speicher, M.R., Rudolph, K.L., 2011. Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction. Nat. Cell Biol. 14, 73-79. Srivastava, M., Nambiar, M., Sharma, S., Karki, S.S., Goldsmith, G., Hegde, M., Kumar, S., Pandey, M., Singh, R.K., Ray, P., Natarajan, R., Kelkar, M., De, A., Choudhary, B., Raghavan, S.C., 2012. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 151, 1474-1487. Steedman, H.F., 1950. Alcian blue 8GS: a new stain for mucin. The Quarterly journal of microscopical science 91, 477-479. Sung, L.Y., Chang, W.F., Zhang, Q., Liu, C.C., Liou, J.Y., Chang, C.C., Ou-Yang, H., Guo, R., Fu, H., Cheng, W.T.K., Ding, S.T., Chen, C.M., Okuka, M., Keefe, D.L., Chen, Y.E., Liu, L., Xu, J., 2014. Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer. Cell reports 9, 1603-1609. Tacconi, E.M., Tarsounas, M., 2015. How homologous recombination maintains telomere integrity. Chromosoma 124, 119-130. Takahashi, K., Yamanaka, S., 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. Temu, T.M., Wu, K.Y., Gruppuso, P.A., Phornphutkul, C., 2010. The mechanism of ascorbic acid-induced differentiation of ATDC5 chondrogenic cells. American journal of physiology. Endocrinology and metabolism 299, E325-334. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., 1998. Embryonic stem cell lines derived from human blastocysts. Science (New York, N.Y.) 282, 1145-1147. Tomaska, L., Nosek, J., Kramara, J., Griffith, J.D., 2009. Telomeric circles: universal players in telomere maintenance? Nat. Struct. Mol. Biol. 16, 1010-1015. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., Mulligan, R.C., 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163. Ulaner, G.A., Hu, J.F., Vu, T.H., Giudice, L.C., Hoffman, A.R., 1998. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58, 4168-4172. Viotti, M., Nowotschin, S., Hadjantonakis, A.K., 2014. SOX17 links gut endoderm morphogenesis and germ layer segregation. Nat. Cell Biol. 16, 1146-1156. Wakayama, T., Tabar, V., Rodriguez, I., Perry, A.C., Studer, L., Mombaerts, P., 2001. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science (New York, N.Y.) 292, 740-743. Wallin, J., Wilting, J., Koseki, H., Fritsch, R., Christ, B., Balling, R., 1994. The role of Pax-1 in axial skeleton development. Development 120, 1109-1121. Wang, R.C., Smogorzewska, A., de Lange, T., 2004. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119, 355-368. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., Campbell, K.H., 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813. Winkler, T., Hong, S.G., Decker, J.E., Morgan, M.J., Wu, C., Hughes, W.M.t., Yang, Y., Wangsa, D., Padilla-Nash, H.M., Ried, T., Young, N.S., Dunbar, C.E., Calado, R.T., 2013. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J. Clin. Invest. 123, 1952-1963. Wozney, J.M., 1992. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32, 160-167. Wright, E., Hargrave, M.R., Christiansen, J., Cooper, L., Kun, J., Evans, T., Gangadharan, U., Greenfield, A., Koopman, P., 1995. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9, 15-20. Yan, L., Wu, S., Zhang, S., Ji, G., Gu, A., 2014. Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility. Gene 534, 139-143. Yang, H., Li, Q., Fan, J., Holloman, W.K., Pavletich, N.P., 2005. The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature 433, 653-657. Young, N.S., Calado, R.T., Scheinberg, P., 2006. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108, 2509-2519. Yu, G.L., Bradley, J.D., Attardi, L.D., Blackburn, E.H., 1990. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344, 126-132. Zalzman, M., Falco, G., Sharova, L.V., Nishiyama, A., Thomas, M., Lee, S.L., Stagg, C.A., Hoang, H.G., Yang, H.T., Indig, F.E., Wersto, R.P., Ko, M.S., 2010. Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464, 858-863. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71813 | - |
dc.description.abstract | 端粒酶(Telomerase)是細胞中負責合成延長端粒的酵素,避免細胞產生端粒缺乏的問題。端粒酶是由一反轉錄酵素telomerase reverse transcriptase(TERT)、一RNA模板telomerase RNA component(TERC)及其他穩定結構的蛋白所組成,當其中任一組成發生突變時便會使端粒酶功能喪失,造成許多老化相關疾病;當端粒酶缺失發生在人類時,多會引發端粒綜合症(telomere syndrome)等罕見疾病,此疾病多帶有短端粒以及中胚層發育缺陷的問題。藉由產製嵌合體小鼠以及四倍體囊胚互補試驗(tetroploid embryo complementation)等幹細胞全能性檢測試驗中也指出,端粒酶缺失(Terc-/-)的幹細胞如胚幹細胞(embryonic stem cells, ESCs)及誘導性全能幹細胞 (induced pluripotent stem cells, iPSCs)存在全能性分化上的缺陷;而另一研究也指出短端粒的iPSCs存在中胚層的分化缺陷,此結果可推測幹細胞的端粒酶缺失可能為造成其分化潛能缺陷的原因之一。此外補救端粒酶缺失所造成的短端粒問題也是重要的研究方向,其中SCR7和RS-1是具有促進同源性重組(homologous recombination, HR)發生的小分子藥物,可藉由非依靠端粒酶活性(telomerease-independent)的HR路徑延長端粒。故本研究藉由野生型、Terc+/-與Terc-/-的核移殖胚幹細胞(nuclear transfer embryonic stem cells, ntESCs)為基礎,針對端粒酶缺失的Terc+/-ntESCs與Terc-/-ntESCs是否存在中胚層分化缺陷,以及SCR7和RS-1能否透過HR補救端粒酶缺失之核移殖胚幹細胞的短端粒及分化潛能問題進行探討。試驗結果發現野生型、Terc+/-與Terc-/-的ntESCs在分化早期並無缺陷產生,但於後期30天的軟骨誘導分化中,證實Terc-/-ntESCs確實存在中胚層的分化缺陷問題,但此分化潛能缺陷卻無法藉由SCR7和RS-1進行補救,即使SCR7和RS-1可有效降低Terc+/-、Terc-/-ntESCs在軟骨分化過程中的細胞凋亡比率,但因端粒延長幅度過小,仍無法彌補端粒酶缺失所造成的短端粒缺陷。然而實際抑制中胚層分化的主因及機制至今仍未明瞭,仍需更多的實驗研究釐清,以利未來應用於治療端粒綜合症病患的臨床研究。 | zh_TW |
dc.description.abstract | Telomerase is an enzyme for telomere elongation to protect cells from telomere insufficient, which is composed of telomerase reverse transcriptase (TERT), telomerase RNA component (TERC) and other stabilizing proteins. Mutations of genes that encode telomerase components like TERT or TERC would lead to premature aging and age-related diseases. In human, telomerase haplo-insufficient would cause the telomere syndromes with symptoms of short telomere and mesodermal defects. Several reports demonstrated that telomerase-deficient (Terc-/-) caused the developmental defects in pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), evidenced by production of mouse chimeras and tetraploid embryo complementation. The short telomeres also affect differentiation potential of PSCs, especially for mesodermal differentiation. On the other hand, SCR7 and RS-1 are small molecule drugs to stimulate homologous recombination (HR) happened. Telomere also can be elongated by HR in T-loop structure without telomerase participation. We hypothesis that SCR7 and RS-1 might an alternative way to elongate the telomere length and futher rescue the pluripotency of telomerase deficient ESCs. Therefore, by using telomerase- deficient (Terc+/- and Terc-/-) nuclear transfer embryonic stem cells (ntESCs), the aim of this project is to study: 1) whether telomerase-deficient affects mesodermal differentiation potential and 2) whether pluripotency of telomerase-deficient ntESCs can be rescued by SCR7 or RS-1. In our data, although there are not significant difference between Terc+/+, Terc+/- and Terc-/- ntESCs in 10 days of spontaneous differentiation, but the mesodermal defect of Terc-/- ntESCs during the late stage of differentiation process was confirmed by the chondrocyte differentiation. Besides, SCR7 and RS-1 can elongate the telomere length and decrease apoptotic rate of Terc-/- ntESCs during the chondrocyte differentiation. However, the defect of mesodermal differentiation in Terc-/- ntESCs wasn’t rescued by SCR7 or RS-1 treatment. Understanding the mechanism between mesodermal defect and short telomere in telomerase-deficient PSCs and the appropriate way for telomere elongation in telomerase-deficient PSCs would provide insights to how to optimally reset telomeres in patient-specific PSCs especially for telomere syndrome patients. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T06:10:43Z (GMT). No. of bitstreams: 1 ntu-107-R05642002-1.pdf: 3569104 bytes, checksum: 4fd736a70780c64a9b87d9300413b267 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 口試委員會審定書……………………………………………Ⅰ
誌謝………………………………………………………….. Ⅱ 摘要……………………………………………………………Ⅲ 目次……………………………………………………………Ⅶ 圖次……………………………………………………………Ⅸ 表次…………………………………………………………Ⅺ 縮寫表………………………………………………..…………Ⅻ 第一章 前言……………………………………………………1 第二章 文獻探討………………………………………………2 2.1 端粒與端粒酶之功能……………………………………………………….….2 2.2 以端粒重組延長端粒………………………………..…………………………..3 2.3端粒酶功能缺失之影響………………………………………………………..6 2.4幹細胞移植治療………………………………………………………………..6 2.5端粒長度影響全能幹細胞之分化………………………………...……………..8 2.6 SCR7和RS-1對於端粒之影響…………………………………………………9 第三章 試驗研究………………………………………………12 3.1不同端粒酶基因型之ntESCs分化潛能檢測.……………………12 3.1.1 前言……………………………………………………………………12 3.1.2 材料與方法……………………………………………………………14 3.1.3 結果……………………………………………………………………24 3.1.4 討論……………………………………………………………………35 3.2 端粒酶基因缺失影響ntESCs在軟骨的分化潛能…..………37 3.2.1 前言……………………………………………………………………37 3.2.2 材料與方法……………………………………………………………39 3.2.3 結果……………………………………………………………………43 3.2.4 討論…...…………………………………………………………………52 3.3 端粒酶缺失的ntESCs之端粒修復……………………………..53 3.3.1 前言……………………………………………………………………53 3.3.2 材料與方法……………………………………………………………54 3.3.3 結果……………………………………………………………………57 3.3.4 討論……………………………………………………………………69 第四章 綜合討論………………………………………………71 第五章 總結與未來展望………………………………………73 參考文獻………………………………………………………74 | |
dc.language.iso | zh-TW | |
dc.title | 端粒酶基因缺失對全能幹細胞分化潛能之影響 | zh_TW |
dc.title | Effects of Telomerase-Insufficiency on Differentiation Potential of Pluripotent Stem Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李宣書(Hsuan-Shu Lee),吳信志(Shinn-Chih Wu),林劭品(Shau-Ping Lin),楊尚訓(Shang-Hsun Yang) | |
dc.subject.keyword | 端粒,端粒?,端粒綜合症,全能幹細胞,分化全能性,軟骨分化,同源性重組, | zh_TW |
dc.subject.keyword | telomere,telomerase,telomere syndrome,pluripotent stem cells,pluripotency,chondrocyte differentiation,homologus recombination, | en |
dc.relation.page | 84 | |
dc.identifier.doi | 10.6342/NTU201804277 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-11-15 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 生物科技研究所 | zh_TW |
顯示於系所單位: | 生物科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 3.49 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。